Q

Quanterix Corp
D

QTRX

12.040
USD
-0.38
(-3.06%)
مغلق
حجم التداول
9,798
الربح لكل سهم
-1
العائد الربحي
-
P/E
-12
حجم السوق
462,083,557
نظرة عامةالتوصياتالأفكار والتحليلاتالأخبار
أصول ذات صلة
    A
    ARCT
    -2.310
    (-12.60%)
    16.020 USD
    B
    BNTX
    -3.740
    (-3.61%)
    99.740 USD
    GSK
    GSK
    -1.020
    (-2.97%)
    33.350 USD
    I
    INO
    -0.54000
    (-11.25%)
    4.26000 USD
    JNJ
    JNJ
    2.140
    (1.41%)
    154.520 USD
    MRNA
    MRNA
    -2.950
    (-7.42%)
    36.830 USD
    N
    NVAX
    0.12000
    (1.67%)
    7.32500 USD
    PFE
    PFE
    -1.225
    (-4.71%)
    25.760 USD
    REGN
    REGN
    -25.40
    (-3.25%)
    756.82 USD
    V
    VIR
    -0.63500
    (-7.35%)
    8.01000 USD
    المزيد
الأخبار

العنوان: Quanterix Corp

القطاع: Healthcare
الصناعة: Medical Devices
Quanterix Corp is a life sciences company. It focuses on developing an ultra-sensitive digital immunoassay platform that advances precision health for life sciences research and diagnostics. The Simoa bead-based and planar array platforms designed by the company enable customers to reliably detect protein biomarkers in low concentrations in blood, serum, and other fluids that are undetectable using conventional, analog immunoassay technologies. Its products include Simoa, Assay Kits, LDTs & Assay Services, Simoa p-Tau 217, Simoa NfL LDT, Simoa p-Tau 181 LDT, Instruments, HD-X Automated Immunoassay Analyzer, SR-X Biomarker Detection System, SP-X Imaging and Analysis System, Simoa Accelerator Laboratory, Homebrew - Custom Assay Development, and Uman NF-Light.